Sandbox/Alejandro

Jump to navigation Jump to search

Neutropenic Patients

  • Patients with neutropenia require an antimicrobial therapy with a broader coverage.
  • The duration of antimicrobial therapy should be individualized in accordance with patient's clinical response.
Recommended Duration of Antimicrobial Therapy Based on the Microorganism.
Microorganism Duration of Therapy
 ▸ Gram-negative Bacteria 7-14 days
 ▸ Gram-positive Bacteria 7-10 days
 ▸ Fungi Until clinical resolution

▸ Click on the following categories to expand treatment regimens.

Neutropenia

  ▸  Gram-Negative Bacteria

  ▸  Gram-Positive Bacteria

  ▸  Fungi


Gram-Negative Bacteria
Preferred Regimen
Meropenem 0.5-1 g IV q8h (infuse over 15-30 min or in bolus over 3-5 min)
OR
Imipenem/cilastatin 0.5–1 g IV q6–8h(max: 50mg/kg/day)
OR
Ertapenem 1 g IV/IM q24h'
OR
Cefepime 2g IV q8h
OR
Ceftazidime 2g IV q8h
OR
Piperacillin/tazobactam 3.375 g IV q6–8h
Alternative Regimen 1
Amikacin 15 mg/kg/day IV/IM divided q8-12h (max: 15 mg/kg/day)
OR
Gentamicin 3-5 mg/kg/day IV/IM divided q6-8h
OR
Gentamicin 4-7 mg/kg/day IV q24h (adjust dosage based on serum concentrations)
PLUS
Cefepime 2g IV q8h
OR
Piperacillin/tazobactam 3.375 g IV q6–8h (max 24 g/day)
Alternative Regimen 2
Piperacillin/tazobactam 3.375 g IV q6–8h (max 24 g/day)
PLUS
Ciprofloxacin 400mg IV q8h
Gram-Positive Bacteria
Preferred Regimen
Vancomycin† 15-20 mg/kg IV q8-12h
Alternative Regimen
Linezolid 600 mg IV/PO q12h
OR
Daptomycin 4mg/kg IV q24h
† Vancomycin should be discontinued if culture results remain negative after 72-96 hrs
Fungi
Preferred Regimen
Liposomal Amphotericin B 3 mg/kg/day IV × 1-2 weeks
OR
Amphotericin B deoxycholate 0.7-1 mg/kg/day IV × 1-2 weeks
OR
Amphotericin B lipid complex 5 mg/kg/day IV × 1-2 weeks
Alternative Regimen
Voriconazole 6 mg/kg IV q12h x 1 day, then 3 mg/kg IV q12h
OR
Voriconazole 200 mg PO q12h
OR
Caspofungin 70 mg IV once, then 50 mg IV q24h x ≥ 14 days

Cellular Immune Deficient Patients

  • Patients with cellular immunodeficiency require a pathogen-specific antimicrobial therapy.
  • The duration of antimicrobial therapy should be individualized in accordance with patient's clinical response.
Recommended Duration of Antimicrobial Therapy Based on the Microorganism.
Microorganism Duration of Therapy
 ▸ Nocardia spp 3-12 months
 ▸ Atypical mycobacteria 3-6 weeks
 ▸ Cryptococcus spp 8-12 weeks
 ▸ Histoplasma spp ≥ 12 months
 ▸ Varicella-zoster virus 7-10 days
 ▸ Herpes simplex virus 7 days
 ▸ Cytomegalovirus 21 days


Bacteria

  ▸  Nocardia spp

  ▸  Atypical mycobacteria

Fungi

  ▸  Cryptococcus spp

  ▸  Histoplasma spp

Viruses

  ▸  Varicella-zoster virus

  ▸  Herpes simplex virus

  ▸  Cytomegalovirus

Nocardia spp
Preferred Regimen
TMP-SMX x 3-12 months
Alternative Regimen 1
Sulfadiazine 2-4 g PO 1 dose
FOLLOWED BY
Sulfadiazine 2-4 g/day PO q4-8h x 3-12 months
Alternative Regimen 1
Imipenem 250-500 mg IV q6-8h x 3-12 months
Atypical mycobacteria†
Preferred Regimen
Clarithromycin 500 mg PO q12h
PLUS
Ethambutol 15 mg/kg PO q24h
WITH OR WITHOUT‡
Rifabutin 300 mg PO q24h
Alternative Regimen
Azithromycin 500 mg PO q24h
PLUS
Ethambutol 15 mg/kg PO q24h
WITH OR WITHOUT‡
Rifabutin 300-450 mg PO q24h
† Adapted from Am J Respir Crit Care Med Vol 175. pp 367–416, 2007[1]
Cryptococcus spp
Preferred Regimen
Moderate Severe to Severe Disease
Liposomal Amphotericin B 3 mg/kg/day IV × 1-2 weeks
OR
Amphotericin B deoxycholate 0.7-1 mg/kg/day IV × 1-2 weeks
OR
Amphotericin B lipid complex 5 mg/kg/day IV × 1-2 weeks
FOLLOWED BY
Itraconazole 200 mg PO q12h x ≥12 months
Mild to Moderate Disease
Itraconazole 200 mg PO q12h x ≥12 months
Adapted from Clin Infect Dis. 2007;45(7):807-25.[2]
Histoplasma spp
Preferred Regimen
Liposomal Amphotericin B 3 mg/kg/day x 1- 2 weeks
OR

Amphotericin B lipid complex 5 mg/kg/day x 1- 2 weeks

FOLLOWED BY
Itraconazole 200mg q8h x 3 days
FOLLOWED BY
Itraconazole 200mg q12h x 6-12 months
Varicella-zoster virus
Preferred Regimen
Acyclovir 10-12 mg/kg IV (infusion over 1 hour) q8h x 7-10 days
Alternative Regimen
Famciclovir 500 mg PO x 7-10 days
OR
Valacyclovir 500 mg PO x 7-10 days
Herpes simplex virus
Preferred Regimen
Acyclovir 10 mg/kg IV (infusion over 1 hour) q8h x 7-10 days
Alternative Regimen
Famciclovir 500 mg PO x 7 days
OR
Valacyclovir 500 mg PO x 7 days
Cytomegalovirus
Preferred Regimen
Ganciclovir 5 mg/kg IV q12h x 21 days
Alternative Regimen
Valganciclovir 900 mg PO q12h x 21 days
  1. Griffith, David E.; Aksamit, Timothy; Brown-Elliott, Barbara A.; Catanzaro, Antonino; Daley, Charles; Gordin, Fred; Holland, Steven M.; Horsburgh, Robert; Huitt, Gwen; Iademarco, Michael F.; Iseman, Michael; Olivier, Kenneth; Ruoss, Stephen; von Reyn, C. Fordham; Wallace, Richard J.; Winthrop, Kevin (2007). "An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases". American Journal of Respiratory and Critical Care Medicine. 175 (4): 367–416. doi:10.1164/rccm.200604-571ST. ISSN 1073-449X.
  2. Wheat, LJ.; Freifeld, AG.; Kleiman, MB.; Baddley, JW.; McKinsey, DS.; Loyd, JE.; Kauffman, CA. (2007). "Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America". Clin Infect Dis. 45 (7): 807–25. doi:10.1086/521259. PMID 17806045. Unknown parameter |month= ignored (help)